What Conditions Is Compounding Pharmacy Used For: The 2026 Clinical Guide
Introduction: Why One Medication Doesn’t Fit Every Patient
Compounded prescriptions account for an estimated 1 to 3 percent of all U.S. prescriptions. That may sound like a small slice, but it represents millions of patients whose needs cannot be met by mass-manufactured, off-the-shelf medications.
The FDA defines compounding as a practice in which a licensed pharmacist, physician, or supervised person combines, mixes, or alters drug ingredients to create a medication tailored to an individual patient’s needs. It is, in many ways, a return to the original art of pharmacy: building a medicine around the patient rather than asking the patient to fit the medicine.
One critical point of transparency deserves attention up front: compounded drugs are NOT FDA-approved. The FDA does not review their safety, effectiveness, or quality before they reach patients. That distinction matters, and it shapes how patients and providers should approach compounding responsibly.
The underlying premise is straightforward. Commercially manufactured medications are designed for the “average” patient, which leaves a substantial subset of people underserved: those with allergies to fillers and dyes, those who cannot swallow pills, those who need a dose strength that does not exist commercially, those whose medication has been discontinued, and those whose conditions require formulations that large manufacturers simply do not produce.
This guide explores the full breadth of conditions compounding addresses, including pain management, hormone therapy, dermatology, pediatrics, sports medicine, weight management, thyroid disorders, palliative care, gender-affirming therapy, and more. It goes beyond surface-level lists to explain not just what conditions benefit from compounding, but why commercial medications fall short in each scenario.
The 2026 context underscores the relevance. The global compounding pharmacy market is projected to reach $18.96 to $22.08 billion by 2030 to 2031, reflecting accelerating clinical demand for personalized medicine. This article is published by Nationwide Compounding Rx®, a PCAB-accredited, USP 800 compliant compounding pharmacy serving patients across 47 states.
Understanding When Compounding Is Clinically Appropriate
Compounding is clinically appropriate in five core scenarios:
- A patient needs a different dosage form, such as a liquid instead of a pill.
- A patient is allergic to inactive ingredients, including dyes, preservatives, or fillers.
- The required dose strength is not commercially available.
- The medication is discontinued or in shortage.
- Dietary or lifestyle restrictions require allergen-free formulations, such as gluten-free, sugar-free, or lactose-free versions.
A key regulatory distinction governs how compounding is delivered. Under federal law, 503A pharmacies prepare patient-specific prescriptions for individual patients, while 503B outsourcing facilities produce larger batches for healthcare providers and are subject to current good manufacturing practice (CGMP) requirements. This distinction affects which patients and conditions each type serves.
In every case, compounding requires a valid prescription from a licensed prescriber. It is not a direct-to-consumer workaround.
The adherence benefit is significant. A 2023 survey by the International Academy of Compounding Pharmacists found that over 70 percent of patients receiving compounded medications reported improved treatment adherence compared to conventional therapies. Often, the issue is excipient sensitivity: patients react not to the active drug but to fillers, dyes, preservatives, peanut oil, lactose, gluten, or sugar. Compounding can eliminate these triggers.
Compounding is also deeply integrated into mainstream care. According to the Alliance for Pharmacy Compounding, the median 503A pharmacy dispenses roughly 350 compounded prescriptions per week and collaborates with about 150 prescribers.
Pain Management: The Largest Compounding Category
The reason commercial pain medications fall short is well documented. Oral systemic medications such as opioids, NSAIDs, and muscle relaxants carry risks of addiction, GI distress, dizziness, nausea, fatigue, and other systemic side effects that limit long-term tolerability.
The core compounding solution is topical pain formulations: creams, gels, and ointments that deliver medication directly to the site of pain while minimizing systemic absorption. Commonly compounded pain agents include gabapentin, cyclobenzaprine, baclofen, diclofenac, lidocaine, ketamine, bupivacaine, and flurbiprofen.
A major advantage is combination therapy. Compounding allows multiple pain-modulating agents to be combined into a single topical application, targeting different pain pathways simultaneously. No single commercial product can replicate this approach. These formulations help patients managing neuropathic pain, musculoskeletal pain, arthritis, fibromyalgia, post-surgical pain, and complex regional pain syndrome (CRPS).
For patients who cannot tolerate oral medications due to GI conditions, renal impairment, or polypharmacy concerns, topical compounding offers a viable alternative. Nationwide Compounding Rx® formulates topical creams, gels, and ointments designed for localized treatment with personalized combinations tailored to each patient.
Hormone Replacement Therapy: The Fastest-Growing Compounding Segment
The fundamental gap is clear: commercial HRT products come in fixed doses and limited delivery forms, yet hormone needs are highly individual, varying by age, lab values, symptom profile, and tolerance.
Menopause, Perimenopause, and Bioidentical Hormone Therapy (BHRT)
Women experiencing hot flashes, vaginal dryness, mood swings, sleep disruption, and sexual dysfunction often require precise hormone titration that fixed-dose products cannot provide. Bioidentical hormones, including estrogens (E1 estrone, E2 estradiol, E3 estriol), progesterone (P4), and DHEA, are chemically identical to those produced by the human body. With compounding, doses can be adjusted each refill based on lab results.
An important clinical caveat applies. According to ACOG Clinical Consensus No. 6 (2023), compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist, and evidence to support marketing claims of superior safety and effectiveness is lacking. ACOG does, however, acknowledge appropriate scenarios, such as allergen sensitivity or unavailable dose strengths.
A clear, evidence-supported example is the peanut oil issue: Prometrium, the FDA-approved oral progesterone, contains peanut oil, so patients with peanut allergies require compounded progesterone. Delivery options include troches, transdermal creams, capsules, suppositories, and sublingual solutions.
Testosterone Therapy for Women
There is NO FDA-approved testosterone formulation specifically indicated for women, a point ACOG explicitly notes. This makes compounding pharmacies the primary legitimate source for this treatment.
Low testosterone in women contributes to decreased libido, fatigue, cognitive fog, and reduced sense of well-being. Commercial male testosterone products are inappropriate because the doses are far too high and the delivery forms are not calibrated for female physiology. The compounding solution is low-dose testosterone creams or troches formulated specifically for female dosing ranges, with prescriber oversight and regular lab monitoring.
Andropause and Male Hypogonadism
Men with declining testosterone may need dose strengths or delivery forms not available commercially. Compounding can provide customized testosterone creams, gels, or troches at precise doses, sometimes combined with DHEA or other androgens. Many men prefer topical application over injections, and compounding accommodates this preference while allowing the removal of preservatives or alcohol-based carriers that cause irritation.
Dermatology: Skin Conditions That Demand Custom Formulations
Commercial dermatology products come in standardized concentrations, vehicles, and formulations that may not suit every patient’s skin type, condition severity, or lifestyle. Compounding allows clinicians to customize active ingredient concentrations, combine multiple actives, and select the optimal vehicle for each patient.
Acne and Rosacea
Fixed concentrations of benzoyl peroxide or retinoids may be too irritating, and useful combination products often do not exist commercially. Compounding offers custom-concentration tretinoin, niacinamide, azelaic acid, or antibiotic combinations in a base suited to the patient’s skin. For rosacea, compounded metronidazole, ivermectin, or azelaic acid in gentle bases improves tolerability. Compounding can also replicate discontinued topical antibiotics that patients once relied on.
Hyperpigmentation, Aging, and Scarring
Hydroquinone concentrations are capped in OTC products, and combination formulations such as hydroquinone plus tretinoin plus a corticosteroid are not commercially available as a single product. Compounding provides custom-strength brightening agents like kojic acid and arbutin, as well as personalized anti-aging creams combining retinoids, peptides, and antioxidants. For scarring and stretch marks, tailored silicone-based or combination preparations address specific scar characteristics. Vehicle choice matters: the same active ingredient in a cream versus a gel versus an ointment can perform very differently.
Eczema, Psoriasis, and Atopic Dermatitis
Commercial corticosteroids and immunomodulators come in limited strengths and vehicles. Compounding can produce intermediate-strength corticosteroids, tacrolimus or pimecrolimus in alternative vehicles, and combination anti-inflammatory and antimicrobial formulations for secondarily infected eczema. Critically, patients with atopic dermatitis are often highly sensitive to parabens, formaldehyde releasers, fragrances, and lanolin found in commercial products. Compounding can eliminate all of these. Children with severe eczema frequently need lower-strength, fragrance-free formulations.
Alopecia and Scalp Conditions
Commercial minoxidil comes only in 2 percent and 5 percent strengths. Compounding enables higher-concentration solutions or foams and combination formulations including finasteride, spironolactone, or ketoconazole. Women with androgenetic alopecia may benefit from compounded topical spironolactone or estradiol scalp formulations not available commercially.
Pediatric Compounding: Making Medications Children Will Actually Take
Most commercial medications are dosed for adults, yet pediatric dosing often requires precise weight-based calculations that yield strengths not commercially available. Pediatric compounding is the fastest-growing age group segment, projected at a 7.66 percent CAGR through 2031.
Children frequently refuse medications due to taste, texture, or an inability to swallow pills, leading to treatment failure. Compounding addresses this with child-appropriate dosing, palatable flavors (banana crème, cherry, grape, raspberry, tutti frutti, vanilla butternut), and patient-friendly formats such as flavored liquids, gummies, lollipops, and suppositories.
Specific pediatric conditions addressed through compounding include ADHD, autism spectrum disorder (ASD), eosinophilic esophagitis (EoE), nausea and vomiting, bacterial and fungal infections, acne, seizure disorders, and thyroid conditions. Many children on the autism spectrum have extreme sensory sensitivities, so masking unpleasant flavors and creating preferred textures can be the difference between treatment success and refusal. For EoE, viscous budesonide slurry is a commonly compounded formulation for a condition that long lacked an FDA-approved oral option.
Children with food allergies to peanuts, gluten, or dairy need allergen-free medications, which compounding can guarantee. Nationwide Compounding Rx® offers flavored liquids, gummies, appropriate dosing, and multiple palatable formats to support pediatric adherence.
Thyroid and Adrenal Disorders
Hypothyroidism, Hashimoto’s thyroiditis, and adrenal insufficiency are among the most common endocrine conditions, yet commercial options have real limitations for a subset of patients.
Commercial levothyroxine (T4 only) does not work optimally for everyone. Some patients need a combination of T3 (liothyronine) and T4 at ratios no commercial product offers. Compounding can deliver customized slow-release T3/T4 combination capsules at precise ratios. Patients who prefer desiccated thyroid can receive it in specific doses without sensitivity-causing fillers.
For adrenal insufficiency, commercial hydrocortisone comes in limited tablet strengths, but patients often need small, precise doses (such as 2.5 mg or 7.5 mg) that only compounding can provide. Many commercial thyroid medications contain lactose and fillers that cause GI symptoms; compounded versions can be made lactose-free and filler-free. As individualized T3/T4 protocols gain acceptance, thyroid compounding is expected to grow through 2026 and beyond.
Sports Medicine: Targeted Treatment for Athletes
Athletes have unique needs: faster recovery, localized treatment, avoidance of performance-impairing systemic side effects, and formulations that do not trigger anti-doping violations.
Core applications include topical anti-inflammatory and analgesic preparations for acute and chronic injuries, muscle recovery formulations, and joint-targeted therapies. These address tendinopathy, muscle strains, ligament injuries, joint inflammation, bursitis, and post-surgical rehabilitation. Transdermal delivery of NSAIDs, muscle relaxants, and analgesics allows localized treatment without systemic GI or cardiovascular risk.
A single topical preparation combining diclofenac, cyclobenzaprine, and lidocaine can address inflammation, muscle spasm, and pain simultaneously, with no commercial equivalent. Compounding pharmacies can also formulate medications free of banned substances, an important consideration for competitive athletes. Custom antimicrobial and healing formulations support wound care for abrasions and turf burns. Nationwide Compounding Rx® provides sports medicine compounding for athletic practices and individual athletes.
Weight Management: The GLP-1 Era and What Has Changed in 2026
GLP-1 medications such as semaglutide and tirzepatide became a major compounding category during the 2022 to 2025 drug shortages, when the FDA authorized compounding to fill access gaps.
The 2026 reality is different. According to Scientific American, the FDA officially removed tirzepatide from the shortage list in December 2024 and semaglutide in February 2025. On April 30, 2026, the FDA proposed to formally exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, as reported by Pharmacy Times. Broad shortage-based compounding of GLP-1s is no longer permitted.
Safety drove this shift. As of early 2025, the FDA had received more than 455 adverse event reports linked to compounded semaglutide and more than 320 associated with compounded tirzepatide, many involving dosing errors. Patients who relied on compounded GLP-1s must now transition to FDA-approved products or explore alternative medically supervised approaches.
Compounding still offers legitimate weight management support through other medically supervised medications and appetite suppressants. Nationwide Compounding Rx® serves as the exclusive provider of the RM3® proprietary weight loss medication for Red Mountain Weight Loss® and continues to compound HCG and medical-grade appetite suppressants. As always, working with a reputable, PCAB-accredited pharmacy is essential, and unaccredited online sources carry real risks.
Palliative Care and Hospice: Dignity Through Customized Medication
Patients in palliative or hospice care are often unable to swallow pills, have complex multi-symptom needs, and require medications that prioritize comfort and dignity. Sublingual solutions, transdermal gels, suppositories, and buccal formulations bypass the need for swallowing, which is critical for patients with dysphagia, nausea, or reduced consciousness.
These formulations manage pain, anxiety and agitation, nausea and vomiting, respiratory distress, excessive secretions, and seizures. A single transdermal gel or suppository can combine an opioid analgesic, an antiemetic, and an anxiolytic, reducing the overall medication burden. Transdermal gels applied to the wrist or inner arm can be administered by family caregivers without nursing skills, improving home hospice care. With palliative medications like injectable morphine and lorazepam experiencing shortages, compounding has served as a vital supply chain backup. Ensuring patients receive necessary medications in a tolerable form is a fundamental act of compassionate care.
Gender-Affirming Hormone Therapy (GAHT)
Gender-affirming hormone therapy is a growing yet often overlooked compounding use case. It requires precise, individualized dosing of estradiol, testosterone, progesterone, and anti-androgens, frequently at doses, concentrations, or in delivery forms not available commercially.
Applications include low-dose estradiol creams or gels for transfeminine patients, testosterone creams at female-range doses for transmasculine patients, progesterone formulations, and spironolactone topicals. Commercial testosterone products are dosed for cisgender male hypogonadism, far too high for many GAHT protocols, while commercial estradiol patches and pills offer limited dose flexibility. Compounding also allows allergen-free formulations for patients sensitive to commercial excipients.
For patients in regions with few GAHT providers, compounding pharmacies that ship nationally can improve access. Nationwide Compounding Rx® serves 47 states. GAHT compounding follows the same 503A prescription requirements as all hormone compounding: a valid prescription from a licensed prescriber is required. Working with knowledgeable, affirming healthcare providers and pharmacists is essential.
Additional Specialty Areas Where Compounding Plays a Critical Role
The following applications round out the full clinical picture of compounding’s reach.
Ophthalmology
Many ophthalmic medications require preservative-free formulations, as preservatives cause ocular surface toxicity with chronic use, along with specific concentrations or combination preparations. Examples include preservative-free antibiotic/steroid combinations after surgery, compounded bevacizumab for intravitreal injection in macular degeneration, and custom artificial tears for severe dry eye. Ophthalmic preparations must be sterile, requiring rigorous quality standards.
Dentistry and Oral Health
Dental procedures require topical anesthetics, antimicrobials, and wound care preparations in concentrations not commercially available. Examples include custom lidocaine or benzocaine gels, antimicrobial rinses, custom fluoride preparations for high-caries-risk patients, and dry socket formulations. Flavoring improves tolerance, especially for pediatric dental patients.
Podiatry
Foot conditions such as fungal infections, warts, wound care, and neuropathic pain often require topical preparations in custom concentrations. Examples include higher-concentration antifungal creams for resistant onychomycosis, urea preparations for hyperkeratosis, and combination analgesics for diabetic neuropathy. Patients with diabetic foot complications represent a significant group requiring customized wound care.
Neurology and Psychiatry
These specialties often require precise titration, allergen-free formulations, or alternative delivery forms. Low-dose naltrexone (LDN), typically 1.5 to 4.5 mg, is not commercially available and must be compounded for autoimmune conditions, chronic pain, fibromyalgia, and inflammatory diseases. Patients needing precise liquid anticonvulsant doses or dye-free antidepressants and antipsychotics also benefit from compounded preparations.
Fertility and Reproductive Medicine
Fertility protocols require precise hormone preparations. Examples include progesterone suppositories or vaginal preparations for luteal phase support, customized estradiol preparations, and HCG formulations. Commercial progesterone in oil injections contains sesame or peanut oil, so patients with allergies need alternatives prepared in different oil bases. Given how much is at stake in fertility treatment, tolerability and adherence are paramount.
Urology
Urological conditions including erectile dysfunction, interstitial cystitis, and overactive bladder may require customized preparations. Examples include topical or intracavernosal preparations for erectile dysfunction and bladder instillation cocktails (heparin, lidocaine, and sodium bicarbonate combinations) for interstitial cystitis. The latter is a well-established compounding application with no commercial equivalent.
Drug Shortages: Compounding as a Critical Healthcare Safety Net
There were 323 drugs on the FDA’s active shortage list in Q1 2024, a record high affecting nearly every specialty. Under sections 503A and 503B of the FD&C Act, compounding pharmacies can prepare copies of FDA-approved drugs during active FDA-recognized shortages, subject to specific conditions.
The APC 2025 to 2026 Snapshot found that more than half of responding pharmacies reported compounding copies of FDA-approved drugs during active shortages. Concrete examples include oncology drug shortages (carboplatin, cisplatin), injectable antibiotic shortages, pediatric liquid medication shortages, and the GLP-1 shortage of 2022 to 2025.
Compounding pharmacies also replicate medications discontinued by manufacturers due to low profitability, a critical service for patients stabilized on those therapies. As the FDA’s interim bulk drug substances policy (effective January 7, 2025) and the proposed SAFE Drugs Act reshape shortage-based compounding, patients should work with compliant, accredited pharmacies. PCAB accreditation and USP compliance are non-negotiable when sourcing during shortages. Nationwide Compounding Rx® is equipped to replicate discontinued medications and respond to shortage needs.
The 2026 Regulatory Landscape: What Patients and Providers Need to Know
The regulatory environment is actively evolving, making current context essential. Key 2025 to 2026 developments include the FDA’s interim bulk drug substances policy (effective January 7, 2025), state-level legislation in Florida and California and the federal SAFE Drugs Act introduced in December 2025, and new California Board of Pharmacy rules effective October 1, 2025.
The GLP-1 closure stands out: the FDA’s April 30, 2026 proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List effectively ends large-scale GLP-1 compounding.
Looking ahead, the FDA’s Pharmacy Compounding Advisory Committee is scheduled to meet July 23 to 24, 2026 to discuss seven peptides (BPC-157, TB-500, KPV, MOTs-C, Semax, Epitalon, and Emideltide) for potential inclusion on the 503A Bulks List. These research peptides have been widely compounded for sports medicine and anti-aging applications, but their regulatory status remains uncertain and under active review.
For patients and providers, the practical guidance is straightforward: work only with PCAB-accredited, USP 800 compliant pharmacies; verify adherence to current state and federal guidelines; and ensure a valid prescription from a licensed prescriber. Regulatory compliance is a patient safety issue, not a formality. Nationwide Compounding Rx® maintains PCAB accreditation, USP 800 compliance, FDA-inspected vendor sourcing, and full adherence to state and federal guidelines.
How to Know If Compounding Is Right for Your Condition
Patients and providers can use the following decision framework:
- Is there an FDA-approved commercial product that meets the patient’s needs? If yes, that should generally be the first choice.
- Does the patient have allergies or intolerances to ingredients in commercial products?
- Is the required dose strength commercially available?
- Can the patient take the commercially available dosage form?
- Is the medication in shortage or discontinued?
- Does the condition require a combination of medications not available in a single commercial product?
The conversation starts with a healthcare provider, since compounding requires a valid prescription and clinical evaluation. Compounded drugs are not FDA-approved, so quality and safety depend heavily on the pharmacy’s accreditation, compliance standards, and sourcing. When evaluating a pharmacy, look for PCAB accreditation, USP 800 compliance, FDA-inspected ingredient sourcing, state licensure, and transparent prescriber communication.
The practical payoff is adherence: when medications are tolerable, palatable, and convenient, patients take them consistently. Nationwide Compounding Rx® offers PCAB accreditation, USP 800 compliance, 40 years of combined staff experience, service across 47 states, and a 1 to 2 business day turnaround.
Conclusion: Personalized Medicine Is Not a Trend, It Is a Clinical Necessity
Across pain management, hormone therapy, dermatology, pediatrics, sports medicine, thyroid disorders, palliative care, gender-affirming therapy, and beyond, one common thread emerges: mass-manufactured medications leave a significant subset of patients underserved.
Compounding pharmacy exists not to circumvent the pharmaceutical system, but to fill the gaps it cannot address, serving patients with allergies, specialized dosing needs, swallowing difficulties, discontinued medications, and conditions requiring formulations that do not exist commercially. It is not appropriate for every patient. FDA-approved products should be the first choice when they adequately meet patient needs. Compounding is a solution for specific, documented clinical gaps.
In 2026, with the regulatory landscape evolving and demand for personalized medicine accelerating, working with a reputable, accredited compounding pharmacy has never been more important. Every patient deserves a medication that works for their body, their lifestyle, and their specific clinical needs. That is the promise of compounding pharmacy. As a PCAB-accredited, USP 800 compliant pharmacy with 40 years of combined experience serving patients and providers across 47 states, Nationwide Compounding Rx® is committed to the art and science of personalized medication.
Ready to Explore Compounding for Your Patients or Your Own Care?
For healthcare providers: Contact Nationwide Compounding Rx® to discuss patients’ specific needs, explore formulation options, and establish a collaborative prescribing relationship. The pharmacy offers a 1 to 2 business day turnaround, nationwide shipping to 47 states, and expertise across all major therapeutic areas.
For patients: Speak with a healthcare provider about whether compounding is appropriate for your condition, and ask specifically about Nationwide Compounding Rx® as a PCAB-accredited option.
Contact Information:
- Phone: 480-499-8379
- Toll-Free: 1-833-650-9836
- Website: www.NationwideCompounding.com
- Address: 14000 N. Hayden Rd., Suite 104, Scottsdale, AZ 85260
- Hours: Monday through Friday, 7:00 a.m. to 3:30 p.m.
Nationwide Compounding Rx® ships to 47 states plus Washington, D.C. States not currently served include Alabama, California, North Carolina, and South Carolina.
The pharmacy purchases only the highest-grade chemicals from FDA-inspected and cleared vendors, follows all state and federal guidelines, and maintains PCAB accreditation, because medication safety is never negotiable.
